FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1806009674> ?p ?o ?g. }

• W1806009674 endingPage "2286" @default.
• W1806009674 startingPage "2274" @default.
• W1806009674 abstract "Currently, exosomes that act as mediators of intercellular communication are being researched extensively. Our previous studies confirmed that these exosomes contain microRNAs (miRNAs) that could alter chemo-susceptibility, which is partly attributed to the successful intercellular transfer of multidrug resistance (MDR)-specific miRNAs. We also confirmed that β-elemene could influence MDR-related miRNA expression and regulate the expression of the target genes PTEN and Pgp, which may lead to the reversal of the chemoresistant breast cancer (BCA) cells. We are the first to report these findings, and we propose the following logical hypothesis: β-elemene can mediate MDR-related miRNA expression in cells, thereby affecting the exosome contents, reducing chemoresistance transmission via exosomes, and reversing the drug resistance of breast cancer cells.MTT-cytotoxic, miRNA microarray, real-time quantitative PCR, Dual Luciferase Activity Assay, and Western blot analysis were performed to investigate the impact of β-elemene on the expression of chemoresistance specific miRNA and PTEN as well as Pgp in chemoresistant BCA exosomes.Drug resistance can be reversed by β-elemene related to exosomes. There were 104 differentially expressed miRNAs in the exosomes of two chemoresistant BCA cells: adriacin (Adr) - resistant MCF-7 cells (MCF-7/Adr) and docetaxel (Doc) - resistant MCF-7 cells (MCF-7/Doc) that underwent treatment. Of these, 31 miRNAs were correlated with the constant changes in the MDR. The expression of miR-34a and miR-452 can lead to changes in the characteristics of two chemoresistant BCA exosomes: MCF-7/Adr exosomes (A/exo) and MCF-7/Doc exosomes (D/exo). The PTEN expression affected by β-elemene was significantly increased, and the Pgp expression affected by β-elemene was significantly decreased in both cells and exosomes. β-elemene induced a significant increase in the apoptosis rate in both MCF-7/Doc and MCF-7/Adr cells.Drug resistance can be reversed by β-elemene, which can alter the expression of some MDR-related miRNAs, including PTEN and Pgp in MCF-7/Adr and MCF-7/Doc in cells. It can therefore affect the exosome contents and induce the reduction of resistance transmission via exosomes." @default.
• W1806009674 created "2016-06-24" @default.
• W1806009674 creator A5018568072 @default.
• W1806009674 creator A5033216492 @default.
• W1806009674 creator A5034188544 @default.
• W1806009674 creator A5060957631 @default.
• W1806009674 creator A5071672663 @default.
• W1806009674 creator A5078096093 @default.
• W1806009674 date "2015-01-01" @default.
• W1806009674 modified "2023-10-03" @default.
• W1806009674 title "β-Elemene Reverses Chemoresistance of Breast Cancer Cells by Reducing Resistance Transmission via Exosomes" @default.
• W1806009674 cites W1968781825 @default.
• W1806009674 cites W1969607893 @default.
• W1806009674 cites W1972916986 @default.
• W1806009674 cites W1977228095 @default.
• W1806009674 cites W1990965835 @default.
• W1806009674 cites W1991361605 @default.
• W1806009674 cites W2002045237 @default.
• W1806009674 cites W2002221031 @default.
• W1806009674 cites W2011694166 @default.
• W1806009674 cites W2040138014 @default.
• W1806009674 cites W2060805485 @default.
• W1806009674 cites W2061324314 @default.
• W1806009674 cites W2061479001 @default.
• W1806009674 cites W2068966740 @default.
• W1806009674 cites W2069774245 @default.
• W1806009674 cites W2085979770 @default.
• W1806009674 cites W2089516972 @default.
• W1806009674 cites W2090658654 @default.
• W1806009674 cites W2091984900 @default.
• W1806009674 cites W2102992903 @default.
• W1806009674 cites W2105728472 @default.
• W1806009674 cites W2155619104 @default.
• W1806009674 cites W2162961035 @default.
• W1806009674 cites W2168031418 @default.
• W1806009674 cites W2170449834 @default.
• W1806009674 doi "https://doi.org/10.1159/000430191" @default.
• W1806009674 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26279432" @default.
• W1806009674 hasPublicationYear "2015" @default.
• W1806009674 type Work @default.
• W1806009674 sameAs 1806009674 @default.
• W1806009674 citedByCount "76" @default.
• W1806009674 countsByYear W18060096742016 @default.
• W1806009674 countsByYear W18060096742017 @default.
• W1806009674 countsByYear W18060096742018 @default.
• W1806009674 countsByYear W18060096742019 @default.
• W1806009674 countsByYear W18060096742020 @default.
• W1806009674 countsByYear W18060096742021 @default.
• W1806009674 countsByYear W18060096742022 @default.
• W1806009674 countsByYear W18060096742023 @default.
• W1806009674 crossrefType "journal-article" @default.
• W1806009674 hasAuthorship W1806009674A5018568072 @default.
• W1806009674 hasAuthorship W1806009674A5033216492 @default.
• W1806009674 hasAuthorship W1806009674A5034188544 @default.
• W1806009674 hasAuthorship W1806009674A5060957631 @default.
• W1806009674 hasAuthorship W1806009674A5071672663 @default.
• W1806009674 hasAuthorship W1806009674A5078096093 @default.
• W1806009674 hasBestOaLocation W18060096741 @default.
• W1806009674 hasConcept C104317684 @default.
• W1806009674 hasConcept C109541995 @default.
• W1806009674 hasConcept C114851261 @default.
• W1806009674 hasConcept C121608353 @default.
• W1806009674 hasConcept C133936738 @default.
• W1806009674 hasConcept C145059251 @default.
• W1806009674 hasConcept C190283241 @default.
• W1806009674 hasConcept C20518536 @default.
• W1806009674 hasConcept C2777609662 @default.
• W1806009674 hasConcept C2781261824 @default.
• W1806009674 hasConcept C2781340500 @default.
• W1806009674 hasConcept C2994423619 @default.
• W1806009674 hasConcept C502942594 @default.
• W1806009674 hasConcept C54355233 @default.
• W1806009674 hasConcept C55493867 @default.
• W1806009674 hasConcept C62478195 @default.
• W1806009674 hasConcept C86554907 @default.
• W1806009674 hasConcept C86803240 @default.
• W1806009674 hasConcept C89423630 @default.
• W1806009674 hasConcept C95444343 @default.
• W1806009674 hasConcept C96232424 @default.
• W1806009674 hasConceptScore W1806009674C104317684 @default.
• W1806009674 hasConceptScore W1806009674C109541995 @default.
• W1806009674 hasConceptScore W1806009674C114851261 @default.
• W1806009674 hasConceptScore W1806009674C121608353 @default.
• W1806009674 hasConceptScore W1806009674C133936738 @default.
• W1806009674 hasConceptScore W1806009674C145059251 @default.
• W1806009674 hasConceptScore W1806009674C190283241 @default.
• W1806009674 hasConceptScore W1806009674C20518536 @default.
• W1806009674 hasConceptScore W1806009674C2777609662 @default.
• W1806009674 hasConceptScore W1806009674C2781261824 @default.
• W1806009674 hasConceptScore W1806009674C2781340500 @default.
• W1806009674 hasConceptScore W1806009674C2994423619 @default.
• W1806009674 hasConceptScore W1806009674C502942594 @default.
• W1806009674 hasConceptScore W1806009674C54355233 @default.
• W1806009674 hasConceptScore W1806009674C55493867 @default.
• W1806009674 hasConceptScore W1806009674C62478195 @default.
• W1806009674 hasConceptScore W1806009674C86554907 @default.
• W1806009674 hasConceptScore W1806009674C86803240 @default.
• W1806009674 hasConceptScore W1806009674C89423630 @default.

• next